Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 23, 2023Journal of Clinical MedicineOpen Access

Janus Kinase Inhibitors in Rheumatoid Arthritis: An Update on the Efficacy and Safety of Tofacitinib, Baricitinib and Upadacitinib

View Full Paper
Ask AI
Bookmark
Share

Authors

RHRobert HarringtonPHPatricia HarkinsRCRichard Conway

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Harrington et al. (2023) studied this question.

synapsesocial.com/papers/6a761ae29aebbbed36614207https://doi.org/10.3390/jcm12206690
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment2014 · 309 citations
  2. 2Clinical significance of Janus Kinase inhibitor selectivity2018 · 286 citations
  3. 3Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis2019 · 178 citations